Comparative Benchmarking
In the context of the broader market, TTRX competes directly with industry leaders such as IPHA and ASRT. With a market capitalization of $154.90M, it holds a significant position in the sector. When comparing efficiency, TTRX's gross margin of N/A stands against IPHA's 3.59% and ASRT's 14.28%. Such benchmarking helps identify whether Turn Therapeutics Inc is trading at a premium or discount relative to its financial performance.
